Alto Neuroscience, Inc. Common Stock — Quarterly Cash Flow (NYSE:ANRO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 171.91 M157.88 M147.01 M184.69 M276.26 M Total liabilities 32.82 M34.47 M35.45 M33.55 M32.89 M Total equity 139.1 M123.41 M111.56 M151.14 M243.37 M Total liabilities & shareholders' equities 171.91 M157.88 M147.01 M184.69 M276.26 M Total debt 19.94 M20.12 M20.31 M16.17 M13.88 M Net debt 19.94 M20.12 M20.31 M16.17 M13.88 M

News

Top 1% Alto Neuroscience Plummets On Its Shocking Schizophrenia Miss

Jefferies raises Alto Neuroscience stock price target on pipeline

Alto Neuroscience raises $120M to fund depression drug trial

Alto Neuroscience completes enrollment in schizophrenia drug trial

Alto Neuroscience receives patent for depression treatment method

Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating

Tesla and ServiceNow among market cap stock movers on Monday

Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026 (NYSE:ANRO)

Google, Alibaba among market cap stock movers on Monday

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Alto Neuroscience (NYSE:ANRO), Albemarle (NYSE:ALB)

Alto Neuroscience stock initiated at Buy by BTIG on precision psychiatry approach

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)